Irbesartan
Back to searchMolecule Structure
Scientific Name
Irbesartan
Description of the Drug
Irbesartan is an angiotensin receptor blocker used to treat hypertension, delay progression of diabetic nephropathy, and treat congestive heart failure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01029
http://www.drugbank.ca/drugs/DB01029
Brand Name(s)
Aprovel, Avapro, Ifirmasta, Irbesartan, Karvea, Sabervel
Company Owner(s)
Jubilant Generics Ltd, Macleods Pharmaceuticals Ltd, Watson Laboratories Inc, Picket Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Of New York Llc, Zydus Pharmaceuticals Usa Inc, Prinston Pharmaceutical Inc, Chartwell Molecular Holdings Llc, Teva Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Type-1 angiotensin II receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL227 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4246 | |
PharmGKB | PA450084 | |
Human Metabolome Database | HMDB0015163 | |
DrugBank | DB01029 | |
PubChem: Thomson Pharma | 14758693 | 14905264 |
PubChem | 3749 | |
Mcule | MCULE-9617953373 | |
LINCS | LSM-3338 | |
Nikkaji | J549.417F | |
BindingDB | 50042235 | |
EPA CompTox Dashboard | DTXSID0023169 | |
DrugCentral | 1481 | |
Brenda | 196827 | |
ChemicalBook | CB4454663 | |
Guide to Pharmacology | 6908 | 589 |
rxnorm | IRBESARTAN | AVAPRO |
PubChem: Drugs of the Future | 12014641 | |
KEGG Ligand | C07469 | |
ChEBI | 5959 | |
ZINC | ZINC000003872931 |